key articles
Erectile function outcome reporting after clinically localized prostate cancer treatment
Tuesday, 7 August 2007 - In conjunction with the assignment to update the Guidelines for Management of Clinically Localized Prostate Cancer, the American Urological Association Prostate Cancer Guideline Update Panel (Burnett et...
Aurhors: Burnett et al.
The Contribution of Common Medical Conditions and Drug Exposures to Erectile Dysfunction in Adult Males
Wednesday, 1 August 2007 - Erectile dysfunction (ED) occurs more frequently in men with lower urinary tract symptoms (LUTS), diabetes, hypertension, and cardiovascular disease than in men without these comorbidities....
Authors: Francis et al.
Effect of Statin Therapy on Early Return of Potency After Nerve Sparing Radical Retropubic Prostatectomy
Wednesday, 1 August 2007 - Anatomical radical retropubic prostatectomy (RRP) with cavernous nerve preservation has improved the rate of postoperative recovery of erectile function sufficient for sexual intercourse. However,...
Authors: Hong et al.
Diagnosis and management of erectile dysfunction in the primary care setting
Thursday, 12 July 2007 - Recent advances in managing erectile dysfunction (ED) involve the use of oral phosphodiesterase type-5 (PDE-5) inhibitor therapies that have transformed the perception of ED for both the patient and the...
Author: Rosenberg
Efficacy and safety of pomegranate juice on improvement of erectile dysfunction
Thursday, 12 July 2007 - Forest et al. (2007) reported a randomized-controlled trial to examine the efficacy of wonderful variety pomegranate juice versus placebo in improving erections in 53 men with mild to moderate erectile...
Authors: Forest et al
The prevalence of newly diagnosed hyperlipidaemia in men with erectile dysfunction
Monday, 9 July 2007 - Erectile dysfunction (ED) is caused multifactorially and strongly associated with ageing. Other common age-adjusted risk factors include coronary artery disease (CAD), diabetes mellitus (DM), hypertension,...
Authors: Smith et al
Versatile effects of sildenafil: recent pharmacological applications (a review)
Monday, 9 July 2007 - Sildenafil is a phosphodiesterase-5 (PDE5) inhibitor and is predominantly used in the treatment of erectile dysfunction. The original focus of research on sildenafil by the scientists at Pfizer was to treat...
Authors: Uthayathas
Analysis of the efficacy and safety of sildenafil citrate in the geriatric population
Sunday, 8 July 2007 - Epidemiological data show an increasing life-expectancy of the population, and age is not only correlated with increasing morbidity but also an increase in the prevalence of erectile dysfunction (ED). ...
Authors: Muller et al
Erectile dysfunction: a sentinel marker for cardiovascular disease in primary care
Saturday, 7 July 2007 - Erectile dysfunction (ED) is a common, age-related disorder that diminishes quality of life for affected men and their partners. Although most ED is now recognized as organic in origin, both organic...
Authors: Miner & Kuritzky
Is erectile dysfunction an early marker of sub-clinical coronary artery disease?
Author(s): Prof. Piero Montorsi, MD Institute of Cardiology, University of Milan, Centro Cardiologico Monzino, IRCCS, Milan and Dr. Th. Roumequère, Brussels
Source: European Urology Today, February 2005, p. 22-23
Erectile...
Prof. F. Montorsi
